Drug discovery company systematically targeting phosphatases
| Date | Round | Amount |
|---|---|---|
| May 2023 | Seed Anavo Therapeutics raised a EUR8.5M seed extension led by MRL Ventures Fund, with M Ventures, Inkef, Taiho Ventures and Bioqube Ventures, bringing total seed to EUR28M. | $8.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.